View in EDS PDF Full Text

The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.

Saved in:
Bibliographic Details
Title: The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.
Authors: Felsky, D, Szeszko, P, Yu, L, Honer, W G, De Jager, P L, Schneider, J A, Malhotra, A K, Lencz, T, Ikuta, T, Pipitone, J, Chakravarty, M M, Lobaugh, N J, Mulsant, B H, Pollock, B G, Kennedy, J L, Bennett, D A, Voineskos, A N
Source: Molecular Psychiatry. Oct2014, Vol. 19 Issue 10, p1125-1132. 8p.
Subjects: Amyloid, Messenger RNA, Gene expression, Alzheimer's disease risk factors, Brain imaging
Abstract: Prior to intervention trials in individuals genetically at-risk for late-onset Alzheimer's disease, critical first steps are identifying where (neuroanatomic effects), when (timepoint in the lifespan) and how (gene expression and neuropathology) Alzheimer's risk genes impact the brain. We hypothesized that variants in the sortilin-like receptor (SORL1) gene would affect multiple Alzheimer's phenotypes before the clinical onset of symptoms. Four independent samples were analyzed to determine effects of SORL1 genetic risk variants across the lifespan at multiple phenotypic levels: (1) microstructural integrity of white matter using diffusion tensor imaging in two healthy control samples (n=118, age 18-86; n=68, age 8-40); (2) gene expression using the Braincloud postmortem healthy control sample (n=269, age 0-92) and (3) Alzheimer's neuropathology (amyloid plaques and tau tangles) using a postmortem sample of healthy, mild cognitive impairment (MCI) and Alzheimer's individuals (n=710, age 66-108). SORL1 risk variants predicted lower white matter fractional anisotropy in an age-independent manner in fronto-temporal white matter tracts in both samples at 5% family-wise error-corrected thresholds. SORL1 risk variants also predicted decreased SORL1 mRNA expression, most prominently during childhood and adolescence, and significantly predicted increases in amyloid pathology in postmortem brain. Importantly, the effects of SORL1 variation on both white matter microstructure and gene expression were observed during neurodevelopmental phases of the human lifespan. Further, the neuropathological mechanism of risk appears to primarily involve amyloidogenic pathways. Interventions targeted toward the SORL1 amyloid risk pathway may be of greatest value during early phases of the lifespan. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 98712657
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Felsky%2C+D%22">Felsky, D</searchLink><br /><searchLink fieldCode="AR" term="%22Szeszko%2C+P%22">Szeszko, P</searchLink><br /><searchLink fieldCode="AR" term="%22Yu%2C+L%22">Yu, L</searchLink><br /><searchLink fieldCode="AR" term="%22Honer%2C+W+G%22">Honer, W G</searchLink><br /><searchLink fieldCode="AR" term="%22De+Jager%2C+P+L%22">De Jager, P L</searchLink><br /><searchLink fieldCode="AR" term="%22Schneider%2C+J+A%22">Schneider, J A</searchLink><br /><searchLink fieldCode="AR" term="%22Malhotra%2C+A+K%22">Malhotra, A K</searchLink><br /><searchLink fieldCode="AR" term="%22Lencz%2C+T%22">Lencz, T</searchLink><br /><searchLink fieldCode="AR" term="%22Ikuta%2C+T%22">Ikuta, T</searchLink><br /><searchLink fieldCode="AR" term="%22Pipitone%2C+J%22">Pipitone, J</searchLink><br /><searchLink fieldCode="AR" term="%22Chakravarty%2C+M+M%22">Chakravarty, M M</searchLink><br /><searchLink fieldCode="AR" term="%22Lobaugh%2C+N+J%22">Lobaugh, N J</searchLink><br /><searchLink fieldCode="AR" term="%22Mulsant%2C+B+H%22">Mulsant, B H</searchLink><br /><searchLink fieldCode="AR" term="%22Pollock%2C+B+G%22">Pollock, B G</searchLink><br /><searchLink fieldCode="AR" term="%22Kennedy%2C+J+L%22">Kennedy, J L</searchLink><br /><searchLink fieldCode="AR" term="%22Bennett%2C+D+A%22">Bennett, D A</searchLink><br /><searchLink fieldCode="AR" term="%22Voineskos%2C+A+N%22">Voineskos, A N</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Psychiatry%22">Molecular Psychiatry</searchLink>. Oct2014, Vol. 19 Issue 10, p1125-1132. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Amyloid%22">Amyloid</searchLink><br /><searchLink fieldCode="DE" term="%22Messenger+RNA%22">Messenger RNA</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+expression%22">Gene expression</searchLink><br /><searchLink fieldCode="DE" term="%22Alzheimer's+disease+risk+factors%22">Alzheimer's disease risk factors</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+imaging%22">Brain imaging</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Prior to intervention trials in individuals genetically at-risk for late-onset Alzheimer's disease, critical first steps are identifying where (neuroanatomic effects), when (timepoint in the lifespan) and how (gene expression and neuropathology) Alzheimer's risk genes impact the brain. We hypothesized that variants in the sortilin-like receptor (SORL1) gene would affect multiple Alzheimer's phenotypes before the clinical onset of symptoms. Four independent samples were analyzed to determine effects of SORL1 genetic risk variants across the lifespan at multiple phenotypic levels: (1) microstructural integrity of white matter using diffusion tensor imaging in two healthy control samples (n=118, age 18-86; n=68, age 8-40); (2) gene expression using the Braincloud postmortem healthy control sample (n=269, age 0-92) and (3) Alzheimer's neuropathology (amyloid plaques and tau tangles) using a postmortem sample of healthy, mild cognitive impairment (MCI) and Alzheimer's individuals (n=710, age 66-108). SORL1 risk variants predicted lower white matter fractional anisotropy in an age-independent manner in fronto-temporal white matter tracts in both samples at 5% family-wise error-corrected thresholds. SORL1 risk variants also predicted decreased SORL1 mRNA expression, most prominently during childhood and adolescence, and significantly predicted increases in amyloid pathology in postmortem brain. Importantly, the effects of SORL1 variation on both white matter microstructure and gene expression were observed during neurodevelopmental phases of the human lifespan. Further, the neuropathological mechanism of risk appears to primarily involve amyloidogenic pathways. Interventions targeted toward the SORL1 amyloid risk pathway may be of greatest value during early phases of the lifespan. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=98712657
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/mp.2013.142
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 1125
    Subjects:
      – SubjectFull: Amyloid
        Type: general
      – SubjectFull: Messenger RNA
        Type: general
      – SubjectFull: Gene expression
        Type: general
      – SubjectFull: Alzheimer's disease risk factors
        Type: general
      – SubjectFull: Brain imaging
        Type: general
    Titles:
      – TitleFull: The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Felsky, D
      – PersonEntity:
          Name:
            NameFull: Szeszko, P
      – PersonEntity:
          Name:
            NameFull: Yu, L
      – PersonEntity:
          Name:
            NameFull: Honer, W G
      – PersonEntity:
          Name:
            NameFull: De Jager, P L
      – PersonEntity:
          Name:
            NameFull: Schneider, J A
      – PersonEntity:
          Name:
            NameFull: Malhotra, A K
      – PersonEntity:
          Name:
            NameFull: Lencz, T
      – PersonEntity:
          Name:
            NameFull: Ikuta, T
      – PersonEntity:
          Name:
            NameFull: Pipitone, J
      – PersonEntity:
          Name:
            NameFull: Chakravarty, M M
      – PersonEntity:
          Name:
            NameFull: Lobaugh, N J
      – PersonEntity:
          Name:
            NameFull: Mulsant, B H
      – PersonEntity:
          Name:
            NameFull: Pollock, B G
      – PersonEntity:
          Name:
            NameFull: Kennedy, J L
      – PersonEntity:
          Name:
            NameFull: Bennett, D A
      – PersonEntity:
          Name:
            NameFull: Voineskos, A N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2014
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 13594184
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Molecular Psychiatry
              Type: main
ResultId 1